STRIDE DUO Trademark

Trademark Overview

On Thursday, September 5, 2024, a trademark application was filed for STRIDE DUO with the United States Patent and Trademark Office. The USPTO has given the STRIDE DUO trademark a serial number of 98735029. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Tuesday, October 14, 2025. This trademark is owned by Distinct Dermatology Inc.. The STRIDE DUO trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical services for nail fungus treatment; Medical treatment of toenail fungus using antifungal oral medication and topical solutions; Medical treatment of skin using antifungal oral medication and topical solution
stride duo

General Information

Serial Number98735029
Word MarkSTRIDE DUO
Filing DateThursday, September 5, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical services for nail fungus treatment; Medical treatment of toenail fungus using antifungal oral medication and topical solutions; Medical treatment of skin using antifungal oral medication and topical solution

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 5, 2024
Primary Code044
First Use Anywhere DateFriday, July 19, 2024
First Use In Commerce DateFriday, July 19, 2024

Trademark Owner History

Party NameDistinct Dermatology Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPonte Vedra, FL 32081

Trademark Events

Event DateEvent Description
Thursday, September 5, 2024NEW APPLICATION ENTERED
Thursday, September 5, 2024APPLICATION FILING RECEIPT MAILED
Saturday, September 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 18, 2025ASSIGNED TO EXAMINER
Tuesday, March 18, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 18, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 18, 2025NON-FINAL ACTION WRITTEN
Thursday, May 22, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 22, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 14, 2025NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, July 14, 2025COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, July 14, 2025EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, July 24, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 24, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 14, 2025EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, October 14, 2025FINAL REFUSAL E-MAILED
Tuesday, October 14, 2025FINAL REFUSAL WRITTEN
Tuesday, October 14, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, July 24, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

stride treatment medical antifungal medication topical oral using fungus skin solution